Bayer has been going down over 60% since 2015 because of many lawsuits regarding the Round-up debacle for causing cancer and some incidents regarding a blood thinner medication causing fatalities. Now there are some positive things starting to show for this stock, the lawsuits in the US for the fatalities are bought off. Speculations are rising that the market, pricing in a 40 bln dollar liability in the Round-up lawsuits is way too high and will be substantially lower after a long drawn out legal process. The stock bounced of the .786 fib with nice volume, this is the same range where a very solid resistance formed from 2010 till mid 2012 when a s/r flip occured.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.